Coriolis Pharma logo — Science Driven Development and Analytical Support - From Ear...

Coriolis Pharma

Science Driven Development and Analytical Support - From Early Development to Commercialization.

Founded 2008 Germany Germany 170 employees Corporate Round Pharmaceutical

General Information

Company Name Coriolis Pharma
Founded Year 2008
Location Germany Germany +1
Employees 170
Industries Pharmaceutical
Funding Stage Corporate Round
Social

Get notified when Coriolis Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Coriolis Pharma

Coriolis Pharma is a globally operating and science-driven contract research and development organization (CRDO) in the pharmaceutical industry. Founded in 2008 and based in Germany, the company specializes in supporting drug product development of biopharmaceuticals, including gene and cell therapies, and vaccines from early development to commercialization. Coriolis Pharma's services encompass formulation development, lyophilization technologies, and analytics (GMP and non-GMP) for a diverse range of products. With a focus on proteins, peptides, nucleic acids, gene- and cell therapy products, vaccines, and virus(-like) particles up to biosafety level S2, Coriolis Pharma has positioned itself as a leader in providing tailored solutions for its clients. The company's interdisciplinary team of highly skilled scientists and an expert scientific advisory board enables it to offer cutting-edge services. Although there is no publicly available information on last investment and last investment investors at this time, Coriolis Pharma continues to thrive as a privately held and independent company, emphasizing its commitment to delivering high-quality services and solutions to the biopharmaceutical industry.

No funding data available for Coriolis Pharma yet.

Get notified when Coriolis Pharma raises funding

Coriolis Pharma Alternatives & Competitors

Coriolis Pharma vs
Bionavigen
Bionavigen United States

New Drug Development Through Smart Acquisition

1 employees
Biopharma, Pharmaceutical
Coriolis Pharma vs
Alphalyse
Alphalyse Denmark

Create superior biologics & therapies through better analytics | World's #1 in impurity analysis usi...

38 employees
Coriolis Pharma vs

Your Best Partner for Biologics Development and Manufacturing

Post Ipo Equity
135 employees
Biotechnology, Manufacturing

FAQ About Coriolis Pharma

Science Driven Development and Analytical Support - From Early Development to Commercialization.
Coriolis Pharma was founded in 2008.
Coriolis Pharma is headquartered in Germany.
Coriolis Pharma operates in the following industries: Pharmaceutical.
Coriolis Pharma has approximately 170 employees.
Top alternatives and competitors to Coriolis Pharma include Bionavigen, Alphalyse, Mycenax Biotech Inc., IDT Biologika, WuXi Advanced Therapies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Coriolis Pharma and Bionavigen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Coriolis Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes